ATE407702T1 - Liposomale einkapselung von alphastrahlern, und deren verwendung - Google Patents

Liposomale einkapselung von alphastrahlern, und deren verwendung

Info

Publication number
ATE407702T1
ATE407702T1 AT01942205T AT01942205T ATE407702T1 AT E407702 T1 ATE407702 T1 AT E407702T1 AT 01942205 T AT01942205 T AT 01942205T AT 01942205 T AT01942205 T AT 01942205T AT E407702 T1 ATE407702 T1 AT E407702T1
Authority
AT
Austria
Prior art keywords
alphast
emitters
liposomal encapsulation
emitting
radionuclides
Prior art date
Application number
AT01942205T
Other languages
English (en)
Inventor
George Sgouros
James Louis Thomas
David Scheinberg
Michael R Mcdevitt
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE407702T1 publication Critical patent/ATE407702T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
AT01942205T 2000-06-16 2001-06-15 Liposomale einkapselung von alphastrahlern, und deren verwendung ATE407702T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21218600P 2000-06-16 2000-06-16

Publications (1)

Publication Number Publication Date
ATE407702T1 true ATE407702T1 (de) 2008-09-15

Family

ID=22789922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942205T ATE407702T1 (de) 2000-06-16 2001-06-15 Liposomale einkapselung von alphastrahlern, und deren verwendung

Country Status (9)

Country Link
US (1) US20030175206A1 (de)
EP (1) EP1289570B1 (de)
JP (1) JP2003535913A (de)
AT (1) ATE407702T1 (de)
AU (2) AU2001275489B2 (de)
CA (1) CA2411826A1 (de)
DE (1) DE60135743D1 (de)
ES (1) ES2312448T3 (de)
WO (1) WO2001097859A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002211232B2 (en) * 2000-09-15 2006-10-19 Sloan Kettering Institute For Cancer Research Targeted alpha particle therapy using actinium-225 conjugates
CA2555343A1 (en) * 2004-02-10 2005-09-22 Barnes-Jewish Hospital Improved efficacy and safety of targeted particulate agents with decoy systems
GB0423565D0 (en) * 2004-10-22 2004-11-24 Algeta As Formulation
TW200922630A (en) * 2007-09-26 2009-06-01 Nat Health Research Institutes Liposome compositions useful for tumor imaging and treatment
EP3773996A4 (de) 2018-03-26 2022-03-30 Triumf Systeme, vorrichtung und verfahren zur trennung von actinium, radium und thorium
EP3917499A4 (de) * 2019-01-29 2022-10-19 The Johns Hopkins University Adhäsions-/adsorptionsschalter auf nanoteilchen zur erhöhung der tumoraufnahme und zur verzögerung von tumor-clearance
US20230241256A1 (en) * 2020-06-30 2023-08-03 The Johns Hopkins University Non-intuitive combination of drug delivery carriers of the same drug for synergistic growth delay of solid tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394372A (en) * 1980-12-22 1983-07-19 The Procter & Gamble Company Process for making lipid membrane structures
US4624846A (en) * 1983-07-29 1986-11-25 Immunomedics, Inc. Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
US4665897A (en) * 1984-05-25 1987-05-19 Lemelson Jerome H Composition and method for detecting and treating cancer
US5328678A (en) * 1987-11-04 1994-07-12 Vestar, Inc. Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy
US5807572A (en) * 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
DK0429624T3 (da) * 1989-06-19 1994-05-30 Akzo Nobel Nv Radioimmunterapi under anvendelse af alfa-partikelemission
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US5662929A (en) * 1994-12-23 1997-09-02 Universite De Montreal Therapeutic liposomal formulation
WO1999003448A1 (en) * 1997-07-14 1999-01-28 The Board Of Trustees Of The University Of Illinois Materials and methods for making improved micelle compositions
US6060315A (en) * 1997-12-01 2000-05-09 Lockheed Martin Energy Research Corporation Method for facilitating the introduction of material into cells
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi

Also Published As

Publication number Publication date
DE60135743D1 (de) 2008-10-23
AU2001275489B2 (en) 2005-01-27
AU7548901A (en) 2002-01-02
CA2411826A1 (en) 2001-12-27
ES2312448T3 (es) 2009-03-01
US20030175206A1 (en) 2003-09-18
JP2003535913A (ja) 2003-12-02
EP1289570A4 (de) 2004-12-15
WO2001097859A1 (en) 2001-12-27
EP1289570B1 (de) 2008-09-10
EP1289570A1 (de) 2003-03-12

Similar Documents

Publication Publication Date Title
DE60219627D1 (de) Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen
DE60010098D1 (de) 28-epirapaloge
ATE233735T1 (de) Neue phenanthridine
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
FI951138A7 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
ATE294595T1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
CY1106156T1 (el) Νεα χρηση βουδεσονιδης και φορμοτepολης
DE69905170T2 (de) Thiazolopyrimidinderivate
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
EE200000033A (et) Uudsed tetrasoolderivaadid
NO20010228L (no) Farmasøytiske preparater omfattende 2-kinoloner
ATE407702T1 (de) Liposomale einkapselung von alphastrahlern, und deren verwendung
EP1558282A4 (de) Zusammensetzungen gegen krebs und infektionskrankheiten und anwendungsverfahren dafür
DK0977871T3 (da) Neurotrypsin
ATE411036T1 (de) Verwendung von aplidine in der behandlung von pankreaskrebs
ATE335824T1 (de) Isolierte luziferasen sowie deren verwendung
ATE28188T1 (de) Antikonvulsive mittel.
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
DE69937797D1 (de) Alpha-emittierende konstrukte sowie deren verwendung
EA200000163A1 (ru) Противоопухолевое средство
PL358482A1 (pl) Związki do ukierunkowanego wprowadzania
SE9701184D0 (sv) Substanser för att åstadkomma preferens och skapa acceptans
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
ES2170479T3 (es) Agente viral terapeutico que detiene el desarrollo de tumores.
PT980379E (pt) Oligonucleotidos quimericos e sua utilizacao

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties